Nifty
Sensex
:
:
15794.60
53075.77
-4.50 (-0.03%)
48.80 (0.09%)

Pharmaceuticals & Drugs - Domestic

Rating :
61/99

BSE: 506943 | NSE: JBCHEPHARM

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,020.84
  • 31.18
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 12,022.64
  • 1.06%
  • 5.63

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.00%
  • 0.70%
  • 17.86%
  • FII
  • DII
  • Others
  • 9.22%
  • 16.66%
  • 1.56%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.80
  • 8.34
  • 7.52

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.68
  • 19.07
  • 12.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.06
  • 19.47
  • 32.29

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.77
  • 18.92
  • 23.99

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.07
  • 3.62
  • 4.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.21
  • 12.97
  • 15.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
624.59
528.46
18.19%
600.66
548.22
9.57%
593.01
443.56
33.69%
605.99
522.29
16.03%
Expenses
499.66
404.56
23.51%
472.55
377.22
25.27%
466.27
333.47
39.82%
442.31
366.86
20.57%
EBITDA
124.92
123.90
0.82%
128.11
170.99
-25.08%
126.74
110.10
15.11%
163.68
155.42
5.31%
EBIDTM
20.00%
23.44%
21.33%
31.19%
21.37%
24.82%
27.01%
29.76%
Other Income
2.08
25.35
-91.79%
4.53
55.95
-91.90%
19.64
8.39
134.09%
12.97
22.69
-42.84%
Interest
1.62
0.69
134.78%
1.34
1.09
22.94%
1.22
1.72
-29.07%
0.94
3.75
-74.93%
Depreciation
22.11
16.53
33.76%
16.97
17.39
-2.42%
15.73
17.45
-9.86%
17.85
17.29
3.24%
PBT
103.28
132.02
-21.77%
114.33
208.46
-45.15%
129.43
99.33
30.30%
157.87
157.07
0.51%
Tax
18.31
31.21
-41.33%
30.21
54.18
-44.24%
31.54
25.41
24.12%
38.81
37.57
3.30%
PAT
84.97
100.81
-15.71%
84.12
154.28
-45.48%
97.89
73.92
32.43%
119.06
119.51
-0.38%
PATM
13.60%
19.08%
14.00%
28.14%
16.51%
16.67%
19.65%
22.88%
EPS
10.98
13.02
-15.67%
10.85
19.94
-45.59%
12.65
9.55
32.46%
15.38
15.45
-0.45%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
2,424.25
2,042.52
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
Net Sales Growth
18.69%
15.09%
8.00%
16.23%
3.32%
11.10%
7.64%
11.97%
17.98%
8.01%
 
Cost Of Goods Sold
842.94
701.50
630.80
596.46
542.41
552.00
491.41
341.40
413.95
371.52
320.07
Gross Profit
1,581.31
1,341.02
1,143.93
1,046.74
871.35
816.32
740.17
802.81
607.92
494.60
481.80
GP Margin
65.23%
65.66%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
Total Expenditure
1,880.79
1,486.35
1,397.15
1,337.36
1,214.64
1,135.93
1,025.55
964.09
873.67
760.48
701.55
Power & Fuel Cost
-
62.60
61.54
63.29
58.28
54.89
55.28
53.02
46.61
39.75
29.89
% Of Sales
-
3.06%
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
Employee Cost
-
340.60
322.92
288.18
251.10
217.34
175.31
159.56
143.67
130.05
112.66
% Of Sales
-
16.68%
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
14.06%
15.02%
14.05%
Manufacturing Exp.
-
148.68
140.70
150.49
139.83
131.45
119.35
223.53
102.44
61.75
52.97
% Of Sales
-
7.28%
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
General & Admin Exp.
-
43.27
48.14
52.97
53.96
42.26
34.82
32.46
31.69
27.94
31.31
% Of Sales
-
2.12%
2.71%
3.22%
3.82%
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
Selling & Distn. Exp.
-
113.22
116.95
113.59
87.44
78.27
72.72
75.13
73.59
56.04
68.65
% Of Sales
-
5.54%
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
7.20%
6.47%
8.56%
Miscellaneous Exp.
-
76.46
76.11
72.38
81.61
59.72
76.65
79.01
61.72
73.44
68.65
% Of Sales
-
3.74%
4.29%
4.40%
5.77%
4.36%
6.22%
6.91%
6.04%
8.48%
10.72%
EBITDA
543.45
556.17
377.58
305.84
199.13
232.39
206.03
180.12
148.19
105.65
100.32
EBITDA Margin
22.42%
27.23%
21.28%
18.61%
14.09%
16.98%
16.73%
15.74%
14.50%
12.20%
12.51%
Other Income
39.22
116.62
50.90
41.44
55.29
50.16
56.65
10.89
37.70
27.87
28.98
Interest
5.12
7.24
3.26
4.65
3.49
5.37
10.65
6.82
5.93
5.28
24.03
Depreciation
72.66
68.67
66.32
55.64
56.97
47.22
41.22
38.64
28.02
24.66
22.42
PBT
504.91
596.89
358.89
286.99
193.95
229.94
210.82
145.55
151.94
103.57
82.85
Tax
118.87
148.36
76.50
93.02
55.23
45.55
49.58
45.14
25.95
24.13
165.53
Tax Rate
23.54%
24.86%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
PAT
386.04
447.96
272.04
193.47
138.34
184.06
161.14
100.41
61.50
79.44
677.91
PAT before Minority Interest
385.36
448.52
272.39
193.97
138.72
184.40
161.24
100.41
61.50
79.44
677.91
Minority Interest
-0.68
-0.56
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
0.00
0.00
0.00
PAT Margin
15.92%
21.93%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
PAT Growth
-13.93%
64.67%
40.61%
39.85%
-24.84%
14.22%
60.48%
63.27%
-22.58%
-88.28%
 
EPS
49.94
57.95
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28
87.70

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
1,809.72
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
Share Capital
15.46
15.46
16.05
16.71
16.96
16.96
16.96
16.95
16.94
16.94
Total Reserves
1,794.27
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
Non-Current Liabilities
72.47
62.72
64.84
45.66
26.98
31.02
32.62
31.93
40.45
39.52
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.22
0.40
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.40
0.40
7.03
12.14
Long Term Provisions
12.57
7.39
5.73
9.67
12.56
10.43
12.03
12.19
8.23
8.27
Current Liabilities
686.57
516.19
781.54
736.50
693.46
797.22
459.75
276.27
239.48
188.32
Trade Payables
186.92
167.97
117.37
110.39
98.98
90.85
77.51
60.75
60.51
37.09
Other Current Liabilities
89.82
102.67
93.10
119.75
122.15
138.73
103.74
98.06
101.15
78.75
Short Term Borrowings
32.64
29.49
25.80
29.29
48.86
193.02
126.88
81.71
37.28
55.23
Short Term Provisions
377.17
216.06
545.27
477.06
423.47
374.61
151.62
35.76
40.54
17.26
Total Liabilities
2,572.47
2,016.90
2,329.30
2,226.49
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
Net Block
633.65
651.26
620.93
639.50
679.44
440.22
328.56
310.55
334.41
276.31
Gross Block
1,182.55
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
540.54
537.46
456.51
Accumulated Depreciation
548.90
526.17
463.89
414.25
359.10
313.53
273.11
229.99
203.06
180.19
Non Current Assets
678.57
740.83
740.80
717.89
879.15
831.58
586.31
370.37
356.49
331.58
Capital Work in Progress
25.57
16.17
15.09
17.40
3.76
134.89
55.17
46.36
4.81
39.00
Non Current Investment
12.91
69.45
95.88
49.96
185.84
231.42
184.83
2.75
2.99
3.00
Long Term Loans & Adv.
5.62
3.59
8.31
10.15
9.43
22.63
17.74
10.71
14.28
13.27
Other Non Current Assets
0.82
0.36
0.59
0.88
0.67
2.43
0.00
0.00
0.00
0.00
Current Assets
1,893.89
1,276.08
1,588.51
1,508.59
1,207.14
1,182.16
900.94
980.65
943.71
866.22
Current Investments
664.97
333.81
360.65
383.77
224.96
247.28
366.78
497.26
394.68
298.92
Inventories
347.45
274.67
243.76
213.73
200.17
187.98
150.27
134.40
104.53
101.03
Sundry Debtors
389.02
345.43
308.22
300.73
265.97
272.64
262.35
235.51
191.27
136.05
Cash & Bank
30.85
30.95
36.80
29.92
13.39
12.90
25.19
11.81
156.23
219.53
Other Current Assets
461.61
18.89
33.23
12.94
502.66
461.34
96.35
101.68
96.99
110.69
Short Term Loans & Adv.
436.39
272.33
605.85
567.50
488.30
458.83
95.97
101.48
96.84
110.29
Net Current Assets
1,207.33
759.88
806.97
772.10
513.68
384.94
441.19
704.37
704.23
677.90
Total Assets
2,572.46
2,016.91
2,329.31
2,226.48
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
314.78
275.75
194.33
122.92
201.13
140.41
126.66
-13.98
84.20
879.69
PBT
596.89
348.89
286.99
193.95
229.94
212.23
145.55
87.44
103.57
843.44
Adjustment
-46.17
7.95
23.72
16.91
13.11
-1.40
38.51
20.75
-4.40
33.13
Changes in Working Capital
-94.21
9.70
-51.47
-47.07
5.92
-16.96
-19.52
-93.71
9.47
167.35
Cash after chg. in Working capital
456.50
366.55
259.24
163.79
248.97
193.88
164.53
14.49
108.65
1,043.91
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-141.72
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-230.68
23.93
-27.67
-20.68
-45.31
-27.62
-111.89
-142.50
-116.05
-260.92
Net Fixed Assets
-12.39
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
Net Investments
-274.62
53.26
-22.80
-22.92
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
Others
56.33
65.09
24.95
31.80
39.66
174.30
19.13
15.39
21.67
23.05
Cash from Financing Activity
-87.42
-306.05
-155.74
-59.52
-183.84
-99.62
-1.39
12.04
-31.45
-526.12
Net Cash Inflow / Outflow
-3.31
-6.38
10.92
42.72
-28.02
13.17
13.38
-144.43
-63.30
92.65
Opening Cash & Equivalents
25.75
32.14
21.24
-21.47
6.54
-5.46
11.81
156.23
219.53
126.89
Closing Cash & Equivalent
22.47
25.75
32.14
21.24
-21.47
9.42
25.19
11.81
156.23
219.53

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
234.17
185.75
184.47
172.50
160.77
139.57
117.31
123.07
119.21
113.34
ROA
19.55%
12.53%
8.52%
6.43%
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
ROE
27.64%
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
ROCE
36.53%
23.71%
19.59%
13.70%
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
Fixed Asset Turnover
1.73
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
1.85
Receivable days
65.62
67.22
67.63
73.15
71.84
79.28
78.41
75.30
68.16
108.62
Inventory Days
55.59
53.31
50.81
53.43
51.77
50.12
44.83
42.16
42.80
47.97
Payable days
92.33
38.74
32.21
33.66
32.86
32.45
27.82
26.91
26.15
26.89
Cash Conversion Cycle
28.88
81.79
86.23
92.93
90.75
96.95
95.43
90.54
84.81
129.69
Total Debt/Equity
0.02
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
0.07
Interest Cover
83.43
108.09
62.74
56.54
43.81
20.80
22.33
15.74
20.61
36.10

News Update:


  • JB Chemicals & Pharmaceuticals’ arm to acquire 4.76% stake in Biotech Laboratories
    1st Jun 2022, 16:57 PM

    With this acquisition of the stake, Biotech Laboratories is now wholly owned subsidiary of Unique Pharmaceutical Laboratories FZE

    Read More
  • JB Chem & Pharma - Quarterly Results
    26th May 2022, 15:33 PM

    Read More
  • JB Chemicals acquires brand 'Azmarda' from Novartis
    13th Apr 2022, 10:34 AM

    Azmarda indicated for heart failure patients with reduced ejection fraction

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.